| Property, plant and equipment |
14.Property, plant and equipment Property, plant and equipment consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Euros in thousands) |
|
Laboratory
equipment |
|
|
Computer
equipment |
|
|
Office
equipment
and
installations |
|
|
Lease hold
improvements |
|
|
Total |
|
Cost as of January 1, 2024 |
|
|
30,266 |
|
|
|
6,710 |
|
|
|
4,223 |
|
|
|
25,413 |
|
|
|
66,612 |
|
Additions |
|
|
7,101 |
|
|
|
763 |
|
|
|
709 |
|
|
|
4,306 |
|
|
|
12,879 |
|
Disposals |
|
|
(5 |
) |
|
|
— |
|
|
|
(8 |
) |
|
|
— |
|
|
|
(13 |
) |
Currency translation differences |
|
|
1,045 |
|
|
|
110 |
|
|
|
112 |
|
|
|
1,698 |
|
|
|
2,965 |
|
Cost as of December 31, 2024 |
|
|
38,407 |
|
|
|
7,583 |
|
|
|
5,036 |
|
|
|
31,417 |
|
|
|
82,443 |
|
Accumulated depreciation as of January 1, 2024 |
|
|
(15,750 |
) |
|
|
(4,157 |
) |
|
|
(2,533 |
) |
|
|
(425 |
) |
|
|
(22,865 |
) |
Additions |
|
|
(4,172 |
) |
|
|
(877 |
) |
|
|
(730 |
) |
|
|
(2,847 |
) |
|
|
(8,626 |
) |
Disposals |
|
|
3 |
|
|
|
— |
|
|
|
7 |
|
|
|
— |
|
|
|
10 |
|
Currency translation differences |
|
|
(380 |
) |
|
|
(60 |
) |
|
|
(31 |
) |
|
|
(111 |
) |
|
|
(582 |
) |
Accumulated depreciation as of December 31, 2024 |
|
|
(20,299 |
) |
|
|
(5,094 |
) |
|
|
(3,287 |
) |
|
|
(3,383 |
) |
|
|
(32,063 |
) |
Net book value as of December 31, 2024 |
|
|
18,108 |
|
|
|
2,489 |
|
|
|
1,749 |
|
|
|
28,034 |
|
|
|
50,380 |
|
Cost as of January 1, 2025 |
|
|
38,407 |
|
|
|
7,583 |
|
|
|
5,036 |
|
|
|
31,417 |
|
|
|
82,443 |
|
Additions |
|
|
3,747 |
|
|
|
928 |
|
|
|
471 |
|
|
|
1,102 |
|
|
|
6,248 |
|
Disposals |
|
|
(5,367 |
) |
|
|
(3,046 |
) |
|
|
(1,774 |
) |
|
|
(330 |
) |
|
|
(10,517 |
) |
Currency translation differences |
|
|
(2,426 |
) |
|
|
(222 |
) |
|
|
(227 |
) |
|
|
(3,425 |
) |
|
|
(6,300 |
) |
Cost as of December 31, 2025 |
|
|
34,361 |
|
|
|
5,243 |
|
|
|
3,506 |
|
|
|
28,764 |
|
|
|
71,874 |
|
Accumulated depreciation as of January 1, 2025 |
|
|
(20,299 |
) |
|
|
(5,094 |
) |
|
|
(3,287 |
) |
|
|
(3,383 |
) |
|
|
(32,063 |
) |
Additions |
|
|
(4,450 |
) |
|
|
(1,062 |
) |
|
|
(480 |
) |
|
|
(3,039 |
) |
|
|
(9,031 |
) |
Disposals |
|
|
4,812 |
|
|
|
3,014 |
|
|
|
1,757 |
|
|
|
184 |
|
|
|
9,767 |
|
Currency translation differences |
|
|
920 |
|
|
|
126 |
|
|
|
80 |
|
|
|
438 |
|
|
|
1,564 |
|
Accumulated depreciation as of December 31, 2025 |
|
|
(19,017 |
) |
|
|
(3,016 |
) |
|
|
(1,930 |
) |
|
|
(5,800 |
) |
|
|
(29,763 |
) |
Net book value as of December 31, 2025 |
|
|
15,344 |
|
|
|
2,227 |
|
|
|
1,576 |
|
|
|
22,964 |
|
|
|
42,111 |
|
The Group’s additions include leasehold improvements, lab equipment, office equipment and computer equipment for the research and commercial GMP manufacturing facility construction in Houston, Texas of €5.0 million for the year ended December 31, 2025, of which €0.6 million are in construction. The Group’s additions include leasehold improvements, lab equipment, office equipment and computer equipment for the research and commercial GMP manufacturing facility construction in Houston, Texas of €8.7 million for the year ended December 31, 2024, of which €0.0 million are in construction. The acquired property, plant and equipment include non-cash investments of €0.5 million and €0.8 million for the year ended December 31, 2025 and 2024, respectively. The unpaid investments decreased from €0.8 million as of December 31, 2024 to €0.5 million as of December 31, 2025 which is accounted for in accounts payable. Depreciation expenses consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, |
|
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|
|
(Euros in thousands) |
|
Research and development expenses |
|
|
(6,911 |
) |
|
|
(6,600 |
) |
|
|
(2,419 |
) |
General and administrative expenses |
|
|
(2,120 |
) |
|
|
(2,026 |
) |
|
|
(868 |
) |
Total |
|
|
(9,031 |
) |
|
|
(8,626 |
) |
|
|
(3,287 |
) |
|